Showing results (111-120 of 367) with videos related to

Sort By:
Pageof 37
The Journal of Biological Chemistry|December 4, 2009
BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domainFranz Hagn, Christian Klein, Oliver Demmer, et al.
Leukemia & Lymphoma|March 5, 2013
GA101 induces NK-cell activation and antibody-dependent cellular cytotoxicity more effectively than rituximab when complement is presentDelila J Kern, Britnie R James, Sue Blackwell, et al.
European Journal of Immunology|July 29, 2003
ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanismChristian Klein, Torsten Wüstefeld, Peter C Heinrich, et al.
Methods (San Diego, Calif.)|November 20, 2018
Engineering therapeutic bispecific antibodies using CrossMab technologyChristian Klein, Wolfgang Schaefer, Joerg T Regula, et al.
Biotechnology and Applied Biochemistry|November 27, 2008
Short-hairpin-RNA-mediated silencing of fucosyltransferase 8 in Chinese-hamster ovary cells for the production of antibodies with enhanced antibody immune effector functionVincent Beuger, Klaus-Peter Künkele, Hans Koll, et al.
The Journal of Infectious Diseases|August 4, 2007
Contribution of interleukin-6/gp 130 signaling in hepatocytes to the inflammatory response in mice infected with Streptococcus pyogenesChristian Klein, Eva Medina, Leif Sander, et al.
Neurotoxicity Research|August 5, 2024
Monomeric Amyloid Peptide-induced Toxicity in Human Oligodendrocyte Cell Line and Mouse Brain Primary Mixed-glial Cell Cultures: Evidence for a Neuroprotective Effect of Neurosteroid 3α-O-allyl-allopregnanoloneNwife Getrude Okechukwu, Christian Klein, Hélène Jamann, et al.
British Journal of Sports Medicine|April 29, 2024
Four distinct patterns of anterior cruciate ligament injury in women's professional football (soccer): a systematic video analysis of 37 match injuriesLeonard Achenbach, Hendrik Bloch, Christian Klein, et al.
Materials (Basel, Switzerland)|March 12, 2020
Establishment of Collagen: Hydroxyapatite/BMP-2 Mimetic Peptide CompositesLiane Schuster, Nina Ardjomandi, Marita Munz, et al.
Leukemia & Lymphoma|December 6, 2013
Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphomaFrank Herting, Thomas Friess, Sabine Bader, et al.
Pageof 37